<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-TXU8GIBE</identifier><date>2008</date><creator>Ocvirk, Janja</creator><relation>documents/doc/T/URN_NBN_SI_doc-TXU8GIBE_001.pdf</relation><relation>documents/doc/T/URN_NBN_SI_doc-TXU8GIBE_001.txt</relation><format format_type="issue">1</format><format format_type="volume">12</format><format format_type="type">article</format><format format_type="extent">str. 43-45</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">619899</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-TXU8GIBE</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">cetuksimab</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">protitelesa</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Neželeni učinki zdravljenja z zaviralcem EGFR - cetuksimabom</title></Record>